Aarti Drugs Revenue

Aarti Drugs had revenue of 5.98B INR in the quarter ending September 30, 2024, a decrease of -6.73%. This brings the company's revenue in the last twelve months to 23.80B, down -12.16% year-over-year. In the fiscal year ending March 31, 2024, Aarti Drugs had annual revenue of 25.29B, down -6.90%.

Revenue (ttm)

23.80B

Revenue Growth

-12.16%

P/S Ratio

1.80

Revenue / Employee

22.36M

Employees

1,064

Market Cap

43.03B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	25.29B	-1.87B	-6.90%
Mar 31, 2023	27.16B	2.27B	9.14%
Mar 31, 2022	24.89B	3.34B	15.49%
Mar 31, 2021	21.55B	3.49B	19.31%
Mar 31, 2020	18.06B	2.45B	15.71%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Aarti Drugs News

6 weeks ago - Aarti Drugs shares surge over 2% after arm gets GMP certificate from UK MHRA - Business Upturn
6 weeks ago - Aarti Drugs’ subsidiary Pinnacle Life Science receives GMP certificate from UK MHRA - Business Upturn
2 months ago - Aarti Drugs Buyback Opens Today, Set to Close on 18th September 2024 - Business Upturn
2 months ago - Aarti Drugs announces share buyback at 60% premium - Business Upturn
3 months ago - Aarti Drugs shares surge 10% ahead of board meeting on sixth buyback plan - Business Upturn

More News